Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
IKT
IKT News & Events
-
Add to Watchlist
Trade IKT
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
IKT News
Inhibikase Grants Stock Options to New Employees Under Inducement Plan
Apr 03 2026
Newsfilter
Inhibikase Therapeutics Reports FY 2025 Financial Results
Mar 26 2026
seekingalpha
INHIBIKASE THERAPEUTICS INC: BOFA GLOBAL RESEARCH STARTS COVERAGE WITH A BUY RATING AND A TARGET PRICE OF $6
Jan 21 2026
moomoo
Intuit Shares Rise: 20 Stocks Making Moves in Premarket Trading
Nov 21 2025
Benzinga
Inhibikase Therapeutics Enhances Leadership with Timothy Pigot's Appointment as Chief Commercial and Strategy Officer
Aug 19 2025
Newsfilter
Inhibikase Therapeutics Announces Second Quarter 2025 Financial Results and Highlights Recent Activity
Aug 14 2025
Newsfilter
Inhibikase Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Activity
May 14 2025
Newsfilter
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Inhibikase Therapeutics, Inc. (NASDAQ: IKT)
May 05 2025
PRnewswire
Show More News
IKT Events
04/07 08:20
Inhibikase Therapeutics Enrolls First Patient in Pivotal Phase 3 IMPROVE-PAH Study
Inhibikase Therapeutics announced that the first patient has been enrolled in the company's pivotal Phase 3 study IMPROVE-PAH study.
Show More Events
IKT Monitor News
Inhibikase Therapeutics reaches 20-day high amid sector rotation
Feb 23 2026
IKT Earnings Analysis
No Data
People Also Watch
